Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Liver glycogen metabolism plays an important role in glucose homeostasis. Glycogen synthesis is mainly regulated by glycogen synthase that is dephosphorylated and activated by protein phosphatase 1 (PP1) in combination with glycogen-targeting subunits or G subunits. There are seven G subunits (PPP1R3A to G) that control glycogenesis in different organs.
PPP1R3G
is a recently discovered G subunit whose expression is changed along the fasting-feeding cycle and is proposed to play a role in postprandial glucose homeostasis. In this study, we analyzed the physiological function of
PPP1R3G
using a mouse model with liver-specific overexpression of
PPP1R3G
.
PPP1R3G
overexpression increases hepatic glycogen accumulation, stimulates glycogen synthase activity, elevates fasting blood glucose level, and accelerates postprandial blood glucose clearance. In addition, the transgenic mice have a reduced fat composition, together with decreased hepatic triglyceride level. Fasting-induced
hepatic steatosis
is relieved by
PPP1R3G
overexpression. In addition,
PPP1R3G
overexpression is able to elevate glycogenesis in primary hepatocytes. The glycogen-binding domain is indispensable for the physiological activities of
PPP1R3G
on glucose metabolism and triglyceride accumulation in the liver. Cumulatively, these data indicate that
PPP1R3G
plays a critical role in postprandial glucose homeostasis and liver triglyceride metabolism via its regulation on hepatic glycogenesis.
...
PMID:Regulation of glucose homeostasis and lipid metabolism by PPP1R3G-mediated hepatic glycogenesis. 2426 75
Alcoholic liver disease (ALD) is a major health problem worldwide and
hepatic steatosis
is an early response to alcohol consumption. Fat and glycogen are two major forms of energy storage in the liver; however, whether glycogen metabolism in the liver impacts alcohol-induced steatosis has been elusive. In this study, we used a mouse model with overexpression of
PPP1R3G
in the liver to dissect the potential role of glycogen on alcohol-induced
fatty liver
formation.
PPP1R3G
is a regulatory subunit of protein phosphatase 1 and stimulates glycogenesis in the liver. Chronic and binge ethanol (EtOH) feeding reduced glycogen level in the mouse liver and such inhibitory effect of EtOH was reversed by
PPP1R3G
overexpression. In addition,
PPP1R3G
overexpression abrogated EtOH-induced elevation of serum levels of alanine aminotransferase and aspartate aminotransferase, increase in liver triglyceride concentration, and lipid deposition in the liver. EtOH-stimulated sterol regulatory element-binding protein (SREBP)-1c, a master regulator of lipogenesis, was also reduced by
PPP1R3G
overexpression in vivo. In AML-12 mouse hepatocytes,
PPP1R3G
overexpression could relieve EtOH-induced lipid accumulation and SREBP-1c stimulation. In conclusion, our data indicate that glycogen metabolism is closely linked to EtOH-induced liver injury and
fatty liver
formation.
...
PMID:Ethanol-induced hepatic steatosis is modulated by glycogen level in the liver. 2602 6